These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 19786240)

  • 21. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels.
    Vavuranakis M; Latsios G; Aggelis D; Bosinakou I; Karambelas I; Tousoulis D; Toutouzas K; Stefanadis C
    Clin Ther; 2006 Jun; 28(6):860-71. PubMed ID: 16860169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination antiplatelet therapy with aspirin and clopidogrel: the role of antecedent and concomitant doses of aspirin. An analysis of 711 patients.
    Serebruany VL; Malinin AI; Atar D
    Cardiology; 2007; 107(4):307-12. PubMed ID: 17264511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of laropiprant on the antiplatelet activity of co-administered clopidogrel and aspirin.
    De Kam PJ; Luo WL; Wenning L; Ratcliffe L; Sisk CM; Royalty J; Radziszewski W; Wagner JA; Lai E
    Platelets; 2014; 25(7):480-7. PubMed ID: 24206527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in patients after recent ischemic stroke: for the Plavix Use for Treatment of Stroke (PLUTO-Stroke) trial.
    Serebruany VL; Malinin AI; Ziai W; Pokov AN; Bhatt DL; Alberts MJ; Hanley DF
    Stroke; 2005 Oct; 36(10):2289-92. PubMed ID: 16151033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspirin enhances platelet-derived growth factor-induced vascular smooth muscle cell proliferation.
    Harvey R; Bredenberg CE; Couper L; Himmelfarb J
    J Vasc Surg; 1997 Apr; 25(4):689-95. PubMed ID: 9129625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium-Channel Blockers Attenuate the Antiplatelet Effect of Clopidogrel.
    Gremmel T; Durstberger M; Eichelberger B; Koppensteiner R; Panzer S
    Cardiovasc Ther; 2015 Oct; 33(5):264-9. PubMed ID: 26014752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between Inflammation and Aspirin and Clopidogrel Antiplatelet Responses in Acute Ischemic Stroke.
    Sternberg Z; Chichelli T; Sternberg D; Sawyer R; Ching M; Janicke D; Ambrus JL; Yu J; Munschauer F
    J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):327-34. PubMed ID: 26586373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smooth muscle cell migration promoting activity of plasma predicts restenosis in patients with peripheral arterial occlusive disease undergoing angioplasty.
    Roller RE; Janisch S; Kvas E; Schnedl WJ; Binder BR; Wojta J; Korninger C
    Thromb Haemost; 2000 Dec; 84(6):1113-6. PubMed ID: 11154122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance.
    Lev EI; Patel RT; Maresh KJ; Guthikonda S; Granada J; DeLao T; Bray PF; Kleiman NS
    J Am Coll Cardiol; 2006 Jan; 47(1):27-33. PubMed ID: 16386660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired responsiveness to clopidogrel and aspirin in patients with recurrent stent thrombosis following percutaneous intervention for peripheral artery disease.
    Mazur P; Frołow M; Niżankowski R; Sadowski J; Undas A
    Platelets; 2013; 24(2):151-5. PubMed ID: 22497730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of vitamin E supplementation on circulating cell adhesion molecules pre- and post-coronary angioplasty.
    Ferns GA; Forster LA; Williams JC; Tull SP; Verma PK; Starkey B; Gershlick AH
    Ann Clin Biochem; 2000 Sep; 37 ( Pt 5)():649-54. PubMed ID: 11026517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease.
    Tsakiris DA; Tschöpl M; Jäger K; Haefeli WE; Wolf F; Marbet GA
    Atherosclerosis; 1999 Jan; 142(1):193-200. PubMed ID: 9920521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Clopidogrel and Aspirin vs Aspirin Alone on Migraine Headaches After Transcatheter Atrial Septal Defect Closure: The CANOA Randomized Clinical Trial.
    Rodés-Cabau J; Horlick E; Ibrahim R; Cheema AN; Labinaz M; Nadeem N; Osten M; Côté M; Marsal JR; Rivest D; Marrero A; Houde C
    JAMA; 2015 Nov; 314(20):2147-54. PubMed ID: 26551304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Non ST elevation acute coronary syndrome. Some characteristics of coagulation and von Willebrand factor during short term use of ticlopidine or clopidogrel].
    Averkov OV; Slavina NN; Gratsianskiĭ NA
    Kardiologiia; 2003; 43(10):50-9. PubMed ID: 14593356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adding cilostazol to dual antiplatelet therapy achieves greater platelet inhibition than high maintenance dose clopidogrel in patients with acute myocardial infarction: Results of the adjunctive cilostazol versus high maintenance dose clopidogrel in patients with AMI (ACCEL-AMI) study.
    Jeong YH; Hwang JY; Kim IS; Park Y; Hwang SJ; Lee SW; Kwak CH; Park SW
    Circ Cardiovasc Interv; 2010 Feb; 3(1):17-26. PubMed ID: 20118150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is a 300 mg clopidogrel loading dose sufficient to inhibit platelet function early after coronary stenting? A platelet function profile study.
    Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Sabaté M; Hernández-Antolín R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Macaya C
    J Invasive Cardiol; 2004 Jun; 16(6):325-9. PubMed ID: 15156004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions.
    Lepäntalo A; Virtanen KS; Heikkilä J; Wartiovaara U; Lassila R
    Eur Heart J; 2004 Mar; 25(6):476-83. PubMed ID: 15039127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The formation of monocyte-platelet aggregates is independent of on-treatment residual agonists'-inducible platelet reactivity.
    Gremmel T; Kopp CW; Seidinger D; Giurgea GA; Koppensteiner R; Steiner S; Panzer S
    Atherosclerosis; 2009 Dec; 207(2):608-13. PubMed ID: 19616779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment.
    Bernlochner I; Steinhubl S; Braun S; Morath T; Jaitner J; Stegherr J; Mehilli J; von Beckerath N; Schömig A; Kastrati A; Sibbing D
    Thromb Haemost; 2010 Dec; 104(6):1193-200. PubMed ID: 20838744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic stroke.
    Zhao L; Gray L; Leonardi-Bee J; Weaver CS; Heptinstall S; Bath PM
    Platelets; 2006 Mar; 17(2):100-4. PubMed ID: 16421011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.